Galecto, Inc. (GLTO) Analysis

Stock Overview

$6.7
+$0.60 (+0.00%)

Volume: 0

Sector: N/A

Industry: N/A

Price Chart

GLTO Price Chart
Figure 1: GLTO price movement

Technical Indicators

Moving Averages

50-Day MA: N/A

200-Day MA: N/A

Relative Strength Index (RSI)

RSI (14): N/A

Neutral

Support & Resistance

Support: $N/A

Resistance: $N/A

52-Week Range

High: $N/A

Low: $N/A

Fundamental Data

Market Cap

N/A

P/E Ratio

N/A

EPS

$N/A

Beta

N/A

Recent News

Galecto Reports Full-Year 2024 Financial Results

globenewswire.com •

BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced its operating and financial results for the quarter and year ended December 31, 2024.

Read Full Article

Historical Performance

1 Day

N/A

1 Week

N/A

1 Month

N/A

3 Months

N/A

YTD

N/A

Historical Data

Last updated: March 24, 2025

Back to Daily Report